Pharmalot…Pharmalittle…
Make a commentBy Ed Silverman // April 23rd, 2007 // 9:14 pm
Apologies are in order for saying goodnight at such a late hour. The interruption has passed and so Pharmalot returns in time to leave you with these…..
The review process for Amgen’s Aranesp is scrutinized;
Pharma’s UK trade group says relying on breakthroughs is a mistake;